[go: up one dir, main page]

WO2005080549A3 - Trioxacarcine und deren verwendung gegen infektionskrankheiten - Google Patents

Trioxacarcine und deren verwendung gegen infektionskrankheiten Download PDF

Info

Publication number
WO2005080549A3
WO2005080549A3 PCT/EP2005/001696 EP2005001696W WO2005080549A3 WO 2005080549 A3 WO2005080549 A3 WO 2005080549A3 EP 2005001696 W EP2005001696 W EP 2005001696W WO 2005080549 A3 WO2005080549 A3 WO 2005080549A3
Authority
WO
WIPO (PCT)
Prior art keywords
trioxacarcins
use against
against infections
parasites
fungi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2005/001696
Other languages
English (en)
French (fr)
Other versions
WO2005080549A2 (de
Inventor
Oliver Kayser
Hartmut Laatsch
Rajendra Prasad Maskey
Friedrich Hansske
Iris Gruen-Wollny
Elisabeth Helmke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofrontera Discovery GmbH
Original Assignee
Biofrontera Discovery GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofrontera Discovery GmbH filed Critical Biofrontera Discovery GmbH
Publication of WO2005080549A2 publication Critical patent/WO2005080549A2/de
Publication of WO2005080549A3 publication Critical patent/WO2005080549A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft Verwendung von Trioxacarcinen als Mittel zur Behandlung von Infektionskrankheiten verursacht durch Pilze, Parasiten, Viren und Bakterien, sowie neue Trioxacarcine-Derivate als solche, ferner Arzneimittel die diese oder deren Salze enthalten und ferner deren Verwendung zur Behandlung von Tumoren sowie Entzündungserkrankungen oder zur Behandlung von Infektionskrankheiten verursacht durch Pilze, Parasiten, Viren und Bakterien.
PCT/EP2005/001696 2004-02-21 2005-02-18 Trioxacarcine und deren verwendung gegen infektionskrankheiten Ceased WO2005080549A2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102004009921.9 2004-02-21
DE102004009921 2004-02-21
DE102004017793.7 2004-04-05
DE102004017793A DE102004017793A1 (de) 2004-02-21 2004-04-05 Trioxacarcine und deren Verwendung

Publications (2)

Publication Number Publication Date
WO2005080549A2 WO2005080549A2 (de) 2005-09-01
WO2005080549A3 true WO2005080549A3 (de) 2005-12-08

Family

ID=34888817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/001696 Ceased WO2005080549A2 (de) 2004-02-21 2005-02-18 Trioxacarcine und deren verwendung gegen infektionskrankheiten

Country Status (2)

Country Link
DE (1) DE102004017793A1 (de)
WO (1) WO2005080549A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
WO2008109591A1 (en) 2007-03-08 2008-09-12 Lexicon Pharmaceuticals, Inc. Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
US9102697B2 (en) 2010-03-22 2015-08-11 President And Fellows Of Harvard College Trioxacarcins and uses thereof
JP6408478B2 (ja) * 2012-11-26 2018-10-17 プレジデント アンド フェローズ オブ ハーバード カレッジ トリオキサカルシン、トリオキサカルシン−抗体複合体、およびその用途
US20210230178A1 (en) * 2017-08-17 2021-07-29 William Marsh Rice University Trioxacarcin analogs and dimers as potent anticancer agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071428A1 (de) * 1981-07-22 1983-02-09 Kyowa Hakko Kogyo Kabushiki Kaisha Derivate mit antibiotischer Wirkung, herstellbar aus einer Kultur von Streptomycesbottropensis
US4511560A (en) * 1979-10-26 1985-04-16 Kyowa Hakko Kogyo Kabushiki Kaisha Antibiotic substances DC-45, and their use as medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5865293A (ja) * 1981-10-13 1983-04-18 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２からびにそれらの製造法
EP0157203A3 (de) * 1984-04-04 1986-10-01 American Cyanamid Company Antitumor-Mittel LL-D49194 alpha 1, LL-D49194 beta 1, LL-D49194 beta 2, LL-D49194 beta 3, LL-D49194 gamma, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 zeta, LL-D49194 eta, LL-D49194 omega 1, LL-D49194 omega 2 und LL-D49194 omega 3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511560A (en) * 1979-10-26 1985-04-16 Kyowa Hakko Kogyo Kabushiki Kaisha Antibiotic substances DC-45, and their use as medicaments
EP0071428A1 (de) * 1981-07-22 1983-02-09 Kyowa Hakko Kogyo Kabushiki Kaisha Derivate mit antibiotischer Wirkung, herstellbar aus einer Kultur von Streptomycesbottropensis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FUJIMOTO, KAZUHISA ET AL: "Antitumor activity of trioxacarcin C", JOURNAL OF ANTIBIOTICS , 36(9), 1216-21 CODEN: JANTAJ; ISSN: 0021-8820, 1983, XP008048950 *
MASKEY, RAJENDRA P. ET AL: "Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry", JOURNAL OF ANTIBIOTICS , 57(12), 771-779 CODEN: JANTAJ; ISSN: 0021-8820, 2004, XP008048955 *
TAMAOKI, TATSUYA ET AL: "Trioxacarcins, novel antitumor antibiotics. II. Isolation, physicochemical properties and mode of action", JOURNAL OF ANTIBIOTICS , 34(12), 1525-30 CODEN: JANTAJ; ISSN: 0021-8820, 1981, XP008048951 *
TOMITA, FUSAO ET AL: "Trioxacarcins, novel antitumor antibiotics. I. Producing organism, fermentation and biological activities", JOURNAL OF ANTIBIOTICS , 34(12), 1519-24 CODEN: JANTAJ; ISSN: 0021-8820, 1981, XP008048954 *

Also Published As

Publication number Publication date
WO2005080549A2 (de) 2005-09-01
DE102004017793A1 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
WO2009105513A3 (en) Novel compounds and methods for therapy
CY1110230T1 (el) Αναστολεις γυρασης και χρησεις αυτων
WO2010065865A3 (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
ATE448232T1 (de) Substituierte heterozyklen
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
WO2006102504A3 (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors
WO2010067078A8 (en) 3,6-disubstituted xanthylium salts
NO20082862L (no) Nye alkylfosfolipidderivater med redusert cytotoksisitet og anvendelse derav
WO2008082692A3 (en) Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
WO2007067559A3 (en) Antibacterial agents
WO2009015369A3 (en) Isophthalamide derivatives inhibiting beta-secretase activity
UA99434C2 (ru) Применение производных алкилфосфолипидов со сниженной цитотоксичностью
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
WO2007077203A3 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
PT1765360E (pt) Utilizações antivirais de complexos de ácido borínico
WO2007059226A3 (en) Photoactivatable antimicrobial agents
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
WO2008001368A3 (en) Use of stilbene derivatives for treatment and prevention of aquatic mold infections
PT1720867E (pt) Processo para a preparação de ziprasidona

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase